Skip to content
Insights
Science4 min read9 sections

Understanding Sensitivity & Specificity in FTS

Every time a person dips a fentanyl test strip (FTS) into a dissolved drug sample, two fundamental questions arise: How likely is this strip to catch fentanyl if it is actually present? And how likely is it to correctly clear a sample that truly contains no fentanyl? These questions are answered by two statistical measures that underpin all diagnostic testing: sensitivity and specificity. Understanding these concepts is not merely academic.

01

Positive and Negative Predictive Value: What Results Mean for You

While sensitivity and specificity describe the test, the questions that matter most to the person holding the strip are: If my test is positive, how likely is it that fentanyl is actually present? And if my test is negative, how safe am I? These questions are answered by Positive Predictive Value (PPV) and Negative Predictive Value (NPV). PPV = TP / (TP + FP), the proportion of positive results that are truly positive.

The 2×2 Table
Fentanyl Present
Fentanyl Absent
Test Positive
True Positive
False Positive
Test Negative
False Negative
True Negative
02

Published Sensitivity Data for Fentanyl Test Strips

Multiple peer-reviewed studies have assessed fentanyl test strip performance, and the data reveal both strengths and important caveats. Green et al. (2020) tested FTS against 110 street-acquired drug samples using gas chromatography-mass spectrometry as the reference standard. FTS demonstrated the lowest limit of detection (0.100 micrograms per milliliter), a false negative rate of 3.7%, and a false positive rate of 9.6%, outperforming both portable Raman spectrometers and Fourier-transform infrared spectrometers for fentanyl detection.

03

False Negative Causes: Analogs, Dilution, and Timing

A false negative is the most dangerous outcome in drug checking because it falsely reassures the user. Several mechanisms can produce false negatives on fentanyl test strips. First, novel and structurally divergent analogs may evade detection entirely. Sisco et al.

StudyFalse Negative RateFalse Positive RateMethod
Green et al. (2020)3.7%9.6%Field testing, mixed samples
Lockwood et al. (2024)<3% (SC-1)<5%Laboratory, controlled
Subcheck SC-X<1.5%<3%Laboratory + field validation
04

The Sensitivity-Specificity Tradeoff and ROC Curves

A fundamental principle of diagnostic testing is that sensitivity and specificity exist in tension. Adjusting the cutoff threshold to increase one typically decreases the other. Lowering the cutoff concentration on a fentanyl test strip increases sensitivity (fewer false negatives) but decreases specificity (more false positives from cross-reactive substances). Raising the cutoff increases specificity but risks missing low-concentration fentanyl samples.

05

How Lateral Flow Immunoassay Technology Works

Understanding why sensitivity and specificity vary requires a basic grasp of how fentanyl test strips work at the molecular level. FTS are competitive lateral flow immunoassays. The strip contains a nitrocellulose membrane with two zones: a test line (T) and a control line (C). Embedded in the conjugate pad near the sample end are gold nanoparticle-antibody conjugates, where the antibodies have been raised to bind fentanyl molecules.

The Tradeoff
Lowering the detection threshold catches more fentanyl (fewer false negatives) but increases cross-reactivity with non-fentanyl substances (more false positives). There is no free lunch — only engineering tradeoffs.
06

Laboratory Performance vs. Real-World Conditions

A persistent gap exists between how fentanyl test strips perform in controlled laboratory settings and how they perform in the hands of real users under field conditions. In the lab, trained technicians use precise volumes of purified water, calibrated drug standards, and controlled timing. In the real world, users may estimate water volume, fail to adequately crush and homogenize their sample, read results outside the recommended window, or misinterpret faint lines near the detection threshold. Usability research published in Substance Use & Misuse (2025) tested five FTS brands in real-world settings and found that the strips are \\

07

Subcheck SC-1 and SC-X: Engineered for Real-World Reliability

The Subcheck SC-1 fentanyl test strip is designed to address the performance limitations documented in the peer-reviewed literature. With a validated sensitivity of 0.25 micrograms per milliliter (250 ng/mL) and a false negative rate below 3% across more than 100 tested fentanyl analogs, the SC-1 delivers consistent, reliable detection that users can trust in real-world conditions. The less-than-3% false negative rate was established through systematic analog coverage testing, not extrapolated from a handful of compounds. For organizations and programs requiring the highest possible confidence, the Subcheck SC-X reduces the false negative rate to below 1.5%, achieved through enhanced antibody selection and manufacturing quality controls that minimize the lot-to-lot variability that has plagued other products.

08

Practical Interpretation: What Your Test Result Actually Means

Armed with the concepts in this article, here is how to interpret fentanyl test strip results in practice. A POSITIVE result (one line) means fentanyl or a cross-reactive substance has been detected. If you are testing an opioid like heroin or a pressed pill, this result is highly reliable (PPV above 95% in most settings) and you should assume fentanyl is present. If you are testing a stimulant like methamphetamine, cocaine, or MDMA, a positive result may be a true positive or a false positive caused by cross-reactivity, especially at high sample concentrations.

Sources & References
  1. 1. Green TC, Park JN, Gilbert M, et al. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples. International Journal of Drug Policy. 2020;77:102661. 2. Lockwood TLE, Vervoordt A, Lieberman M. High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips. Harm Reduction Journal. 2021;18:30. 3. Sisco E, Rubin S. Assessment of two brands of fentanyl test strips with 251 synthetic opioids reveals blind spots in detection capabilities. Harm Reduction Journal. 2023;20:175. 4. Barratt MJ, et al. Testing the test strips: laboratory performance of fentanyl test strips. Harm Reduction Journal. 2024;21:14. 5. Ti L, et al. Detecting fentanyl using point-of-care drug checking technologies at a supervised injection facility. Drug and Alcohol Dependence. 2020;212:108006. 6. Krieger MS, et al. Use of rapid fentanyl test strips among young adults who use drugs. International Journal of Drug Policy. 2018;61:52-58. 7. Peiper NC, et al. Fentanyl test strips as an opioid overdose prevention strategy: findings from a syringe services program in the Southeastern United States. International Journal of Drug Policy. 2019;63:122-128. 8. Barratt MJ, et al. A lot testing protocol for quality assurance of fentanyl test strips for harm reduction applications. Harm Reduction Journal. 2024;21:138. 9. McMaster E, et al. Usability testing of five fentanyl test strip brands in real-world settings. Substance Use & Misuse. 2025. 10. Validation of a lateral flow chromatographic immunoassay for the detection of fentanyl in drug samples. Drug and Alcohol Dependence. 2022;240:109624. 11. Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clinical Biochemist Reviews. 2008;29(Suppl 1):S49-S52. 12. Trevethan R. Sensitivity, specificity, and predictive values: foundations, pliabilities, and pitfalls in research and practice. Frontiers in Public Health. 2017;5:307.